New diabetes drug tested in kidney patients
NCT ID NCT06929156
First seen Feb 17, 2026 · Last updated Apr 28, 2026 · Updated 9 times
Summary
This study looked at how the body absorbs and removes the drug BGM0504 in people with reduced kidney function compared to healthy volunteers. A total of 34 adults with type 2 diabetes or overweight/obesity took part. The goal was to understand if kidney problems change how the drug works, which helps doctors decide on safe dosing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital, Shandong Province)
Jinan, Shandong, 650100, China
Conditions
Explore the condition pages connected to this study.